EU Agency Demands Cancer Drug Recall Due To Sterility Risks
The European Medicines Agency said Friday that the cancer medicine DepoCyte should be recalled from all European Union countries where alternative treatments are available, after an inspection at Pacira Pharmaceuticals Inc.'s...To view the full article, register now.
Already a subscriber? Click here to view full article